Activation of AMPK prevents obesity and associated metabolic diseases through the promotion of glucose utilization, fatty acid oxidation, and mitochondrial biogenesis in skeletal muscle6. Here, PRKAA1 is linked to obesity due to melanocortin 4 receptor deficiency.